In this segment, Dr. Gregory Vidal discusses the role of estrogen receptor antagonists in the treatment of ER-positive, ...

Some say it’s ‘bad medicine’ not to be prescribing it more to high-risk patients, whereas others think alternative approaches might be better.

Cumulative incidence of ipsilateral invasive breast cancer similar when iiBCs detected at primary surgery in the standard treatment group were considered.

In this segment, Dr. Gregory Vidal explains how hormone, or endocrine, therapies work to slow or stop cancer growth in ...

Many breast cancer drugs block estrogen receptors inside cancer cells. Blocking the receptors early in disease progression staves off metastasis. But most patients with advanced disease eventually ...

When people think about breast cancer treatment, they usually picture chemotherapy, radiation, and surgery. But for many of ...

The role of oestrogen receptor beta (ERβ) in breast cancer continues to be a subject of considerable scientific enquiry. Traditionally overshadowed by its counterpart, ERα, ERβ is now understood to be ...

Estrogen-dependent cancers are cancers that grow in response to the hormone estrogen. These include certain types of breast cancer, uterine cancer, and ovarian cancer. In these cancers, estrogen can ...

An evolving understanding of the risks and benefits of HRT has led to a reevaluation of the role of HRT for breast cancer survivors.

Estrogen, the major female ovarian hormone, can trigger nerve impulses within milliseconds to regulate a variety of physiological processes. At Baylor College of Medicine, Louisiana State University ...